Liaison Healthcare, a global provider of secure cloud-based integration and data management services and solutions, announced today the launch of its Global CRO Integration Hub. The solution provides both pharmaceutical companies and contract research organizations (CROs) with a platform that simplifies the integration and harmonization of clinical patient and operational data across the clinical trial process.
Liaison recognizes the importance of increasing collaboration and improving interoperability for clinical trials between sponsors, CROs, providers and patients. In today's healthcare environment, pharmaceutical companies are outsourcing clinical trials to a variety of CROs. Information is constantly flowing between both entities throughout execution of the clinical trial. Given the number of electronic data capture solutions and trial designs; standardizing data is quite daunting. Adding to this complexity, the U.S. Food and Drug Administration (FDA) prefers all clinical trial information is electronically submitted in the CDISC Study Data Tabulation Model (SDTM) format, which is typically not the way information is stored natively and can vary from firm to firm.
"Pharmaceutical companies continue to increase partnerships with contract research organizations (CRO) for clinical trials as a way to speed drugs to market," said Dan Serretti, Director of Global Clinical Development Integrations at Merck. "Liaison recognizes the importance of increasing collaboration and improving interoperability for clinical trials between sponsors, CROs, providers and patients."
Liaison Healthcare identified the need for a scalable, easy-to-use solution that automates and streamlines data exchange; accurately transforming clinical trials data into a compatible format for pharmaceutical companies, CROs, Government registries and the FDA. The Global CRO Integration Hub provides cloud-based connectivity and translation support to enable interoperability throughout the clinical trial process. By implementing the Global CRO Integration Hub solution, pharmaceutical companies and CROs are able to:
"The success and timing of a clinical trial is highly dependent on the accessibility of accurate and real-time information throughout the process," said Gary Palgon, Vice President, Healthcare Solutions, Liaison Healthcare. "Liaison Healthcare¹s Global CRO Integration Hub streamlines the exchange of data so that critical information can be leveraged into actionable insight, ultimately improving speed-to-market and availability of drugs to improve patient care."
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.